Premium
Periodic benefit‐risk evaluation reports have substantial promise to guide patient care and should be made publicly available
Author(s) -
Fralick Michael,
Kesselheim Aaron S.
Publication year - 2017
Publication title -
pharmacoepidemiology and drug safety
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.023
H-Index - 96
eISSN - 1099-1557
pISSN - 1053-8569
DOI - 10.1002/pds.4177
Subject(s) - pharmacoeconomics , pharmacoepidemiology , medicine , family medicine , library science , pharmacology , intensive care medicine , medical prescription , computer science